1391602-39-3

Basic information

• Product Name: N-{2-[2-(3-methyl-2-oxo-imidazolidin-1-yl)-ethyl]-2,3-dihydro-1H-isoindol-5-yl}-guanidine hydrochloride
• CAS NO: 1391602-39-3
• Molecular Weight: 338.84
• Mol File: 1391602-39-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-{2-[2-(3-methyl-2-oxo-imidazolidin-1-yl)-ethyl]-2,3-dihydro-1H-isoindol-5-yl}-guanidine hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: N-{2-[2-(3-methyl-2-oxo-imidazolidin-1-yl)-ethyl]-2,3-dihydro-1H-isoindol-5-yl}-guanidine hydrochloride(1391602-39-3)
• EPA Substance Registry System: N-{2-[2-(3-methyl-2-oxo-imidazolidin-1-yl)-ethyl]-2,3-dihydro-1H-isoindol-5-yl}-guanidine hydrochloride(1391602-39-3)

Safety Data

• Hazardous Substances Data: 1391602-39-3(Hazardous Substances Data)

Upstream product

• 1093230-98-8 (2,3-dihydro-1H-isoindol-5-yl)-carbamic acid tert-butyl ester 
• 697305-97-8 1-(5-amino-1,3-dihydro-isoindol-2-yl)-2,2,2-trifluoro-ethanone 
• 420-04-2 CYANAMID 
• 1391602-38-2 1-[2-(5-amino-1,3-dihydro-isoindol-2-yl)-ethyl]-3-methyl-imidazolidin-2-one hydrochloride 

Relevant articles and documents

SUBSTITUTED PYRIDINYL-PYRIMIDINES AND THEIR USE AS MEDICAMENTS

The invention relates to new substituted pyridinyl-pyrimidines of formula 1 wherein ring A is a five-membered saturated or unsaturated carbocyclic ring which optionally comprises one, two or three heteroatoms each independently from each other selected from the group N, S and O, wherein R1, R2, R4, R3, R5 and R6 are defined as in claim 1 and wherein ring A is further optionally substituted by one or two further substituents and the pharmaceutically acceptable salts, diastereomers, enantiomers, racemates, hydrates and solvates of the aforementioned compounds.